Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania
Status:
Withdrawn
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The proposed pilot study is a placebo-controlled, parallel group, randomized clinical trial
comparing two treatment strategies in adolescents with mania and prominent psychotic
features. One group will receive a second generation antipsychotic (SGA) and placebo and the
other will receive a SGA and lithium.
The primary double-blind phase of the study will last 8 weeks, followed by a 24-week
extension-phase.